Novavax Inc. sell JPMorgan Chase & Co.
Start price
18.11.25
/
50%
€5.63
Target price
18.11.26
€5.18
Performance (%)
45.95%
Price
18:07
€8.22
Summary
This prediction is currently active. The price for Novavax Inc. has massively increased, which is bad news for the SELL prediction by JPMorgan_Chase___Co_. This prediction currently runs until 18.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | 5.319% | 5.319% |
| iShares Core DAX® | 1,16 % | 3,68 % |
| iShares Nasdaq 100 | 2,59 % | 3,10 % |
| iShares Nikkei 225® | 7,11 % | 10,60 % |
| iShares S&P 500 | 1,26 % | 1,67 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat